| Period Ending | 31-Mar-2010 | 31-Mar-2009 | 31-Mar-2008 | 31-Mar-2007 |
|---|
|
Total Revenue
|
55,643,000
|
57,593,000
|
32,027,000
|
17,473,000
| | Cost of Revenue | 44,357,000 | 53,022,000 | 26,588,000 | 16,596,000 | | |
Gross Profit
|
11,286,000
|
4,572,000
|
5,439,000
|
877,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 64,602,000 | 75,689,000 | 38,441,000 | 22,288,000 | | | |
Operating Income or Loss
|
(8,959,000)
|
(18,096,000)
|
(6,414,000)
|
(4,815,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | (8,959,000) | (18,096,000) | (6,414,000) | (4,815,000) |
|
Interest Expense | (11,918,000) | (8,767,000) | (4,401,000) | (1,593,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | (7,130,000) | (5,352,000) | (5,891,000) | 43,000 |
|
Minority Interest | 15,000 | 15,000 | 274,000 | 12,000 |
|
|
|
Net Income From Continuing Ops | (17,665,000) | (18,111,000) | (2,957,000) | (3,835,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(17,665,000)
|
(18,111,000)
|
(2,957,000)
|
(3,835,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|